Emil D Kakkis
Director, President & CEO · 1 filing · Latest: Apr 16, 2026
Ultragenyx Pharmaceutical Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
RARE | Emil D Kakkis | Director, President & CEO | Apr 16, 2026 | Grant/Award | $0.00 | 76,745 | — | 735,739 |